|
The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment
RECRUITINGN/ASponsored by University Ramon Llull
Actively Recruiting
PhaseN/A
SponsorUniversity Ramon Llull
Started2025-10-01
Est. completion2026-01-01
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06081387
Summary
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Eligibility
Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria: * Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database * Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months. * Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group) * Patients who signed the informed consent * Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes) Exclusion Criteria: * Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin) * Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention * Female subjects who are pregnant * Patients who did not sign the informed consent
Conditions2
DiabetesDiabetes Mellitus, Type 2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Ramon Llull
Started2025-10-01
Est. completion2026-01-01
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06081387